Kate Bingham, Chair of the Government's Vaccine Taskforce, after starting her Novavax trial at the Royal Free Hospital, north London on October 13, 2020.Novavax on Thursday said that its vaccine was 89% effective at preventing cases of COVID-19, based on results from a UK trial.
The vaccine developer said that its shot was 89% effective at preventing symptomatic COVID-19, based on a trial of more than 15,000 patients taking place in the UK. The companyNovavax's stock jumped 19% in after-market trading.
I really want to recommend others to start trading with kathleen_pro trading platform,I’ve had massive growth in my BTC wallet after making several withdrawals from their trading platform,it’s so profitable and secured.I’m doing this because of her legitimacy
They sound like at the flower market. Big announcements, no data to back it up.